Splash Corporation Maxi-Peel Exfoliant product recall (2020-05-22)

Starting date:
May 22, 2020
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-73221

Last updated:

Summary

  • Product:
    1. Maxi-Peel Exfoliant Solution #1;
    2. Maxi-Peel Exfoliant Solution #2;
    3. Maxi-Peel Exfoliant Solution #3
  1. Maxi-Peel Exfoliant Solution #1;
  2. Maxi-Peel Exfoliant Solution #2;
  3. Maxi-Peel Exfoliant Solution #3

Reason

Product sold without market authorization (DIN) in Canada. Product contains tretinoin that is listed on the prescription drug list.

Depth of distribution

Wholesalers, Retailers

Affected products

A. Maxi-Peel Exfoliant Solution #1

DIN, NPN, DIN-HIM

No market authorization

Dosage form

Solution

Strength

  • Tretinoin  0.010%
  • Hydroquinone 2%

Lot or serial number

All lots

Companies

Recalling Firm
New Almanic International Ltd.
114 Norfinch Dr Unit 5
North York
M3N 1X1
Ontario
CANADA
Marketing Authorization Holder
N/A

B. Maxi-Peel Exfoliant Solution #2

DIN, NPN, DIN-HIM

No market authorization

Dosage form

Solution

Strength

  • Tretinoin 0.025%
  • Hydroquinone 2%

Lot or serial number

All lots

Companies

Recalling Firm
New Almanic International Ltd.
114 Norfinch Dr Unit 5
North York
M3N 1X1
Ontario
CANADA
Marketing Authorization Holder
N/A

C.Maxi-Peel Exfoliant Solution #3

DIN, NPN, DIN-HIM

No market authorization

Dosage form

Solution

Strength

  • Tretinoin 0.025%
  • Hydroquinone 2%

Lot or serial number

All lots

Companies

Recalling Firm
New Almanic International Ltd.
114 Norfinch Dr Unit 5
North York
M3N 1X1
Ontario
CANADA
Marketing Authorization Holder
N/A